Approval · Notice of Compliance 14016 · 2013

TRIDURAL: Notice of Compliance 14016

Issued January 10, 2013

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 14016
Date: January 10, 2013
Company: Paladin Labs Inc
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Opioid analgesic

Products in this notice

Brand	DIN	Status today
TRIDURAL	02296381	Marketed
TRIDURAL	02296403	Marketed
TRIDURAL	02296411	Marketed

Medicinal ingredients

TRAMADOL HCL 100 MG per TAB
TRAMADOL HCL 200 MG per TAB
TRAMADOL HCL 300 MG per TAB